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Abstract  
 
Background and aims: The regular overnight migrating motor complex (MMC) ensures that the 
normal fasting small bowel water content (SBWC) is minimised. We have applied our recently 
validated non-invasive magnetic resonance technique to assess SBWC in newly diagnosed 
coeliac disease (CD), scleroderma (SCD) and irritable bowel syndrome (IBS) conditions, possibly 
associated with small intestinal bacterial overgrowth (SIBO). 
Methods: 20 CD and 15 SCD patients with gastrointestinal symptoms were compared to 20 
healthy volunteers (HV) and 26 IBS with diarrhoea (IBS-D) patients as previously reported. All 
underwent a fasting, magnetic resonance imaging (MRI) scan on a 1.5 T Philips Achieva MRI 
scanner to assess fasting SBWC and colonic volumes. Stool and symptom diaries were 
completed for 1 week. 
Results: Median (Interquartile range, IQR)  
Compared to healthy volunteers, all the patients had significantly increased stool frequency and 
Bristol stool form score. SBWC was significantly increased in CD 109(53-224) vs. 53(31-98) mL 
in HV, p<0.01 and 42 (28-67) in IBS-D, p<0.01. Variable increase in SBWC was also found in 
SCD, median 77(39-158) but this was not significant, p=0.2. Colonic volumes were similar for all 
 groups being 547 (442-786) for CD, 511 (453-789) for SCD, 612 (445-746) for HV and 521 (428-
757) mL for IBS-D. When CD patients were subdivided according to the Marsh classification, the 
higher grades had larger colonic volumes. 
Conclusion: Fasting SBWC as assessed by MRI is significantly increased in newly diagnosed 
CD and SCD but decreased in IBS-D. Future studies should test whether increased resting fluid 
predisposes to SIBO.  
Key words:  
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Key Summary 
1. Summarise the established knowledge on this subject 
 There is limited published data on the normal motor patterns of the small bowel and 
resting small bowel water content in the human gastrointestinal tract 
 The novel MRI technique is a non-invasive tool that has helped to shed some light on 
the human gastrointestinal physiology  
 The MRI technique is able to assess fasting small bowel water 
 The MRI technique is able to assess colonic volumes 
2. What are the significant and/or new findings of this study? 
 The fasting small bowel water content in patients with newly diagnosed coeliac disease 
and scleroderma is increase 
 A small subgroup of patients with coeliac disease who has more severe mucosal 
damage based on the Marsh grading was associated with large colonic volumes.  
 The increased water secretion in the small bowel may predispose these groups of 
patients to small intestinal bacterial overgrowth.  
 Further larger studies would be needed to affirm this hypothesis.  
 
Introduction  
 
The normal fasting small bowel contains little resting secretions since the interdigestive migrating 
motor complex, which passes down the bowel every 1-2 hours, clears these into the colon [1]. 
This is important as it prevents excessive bacterial proliferation which would otherwise damage 
the small intestinal mucosa leading in severe cases to malabsorption. Diseases such as 
 scleroderma which impair MMCs[2] can be complicated by small intestinal bacterial overgrowth 
(SIBO) which can be prevented by stimulating MMCs with octreotide [3]. Assessment of the 
motor patterns which lead to increased resting secretions and hence provide fertile conditions for 
bacterial growth, has until recently required intestinal intubation so there is little published data. 
Early radiological studies in coeliac disease noted the increase in resting fluids which caused a 
characteristic dilution and flocculation of barium solutions but they were not able to quantify this 
[4]. We have validated a novel MRI technique for assessing small bowel water content (SBWC) 
[5] . We have also shown  that Ondansetron, a 5HT-3 receptor antagonist (5-HT3RA) shown to 
be effective in IBS-D, normalized fasting SBWC while reducing antroduodenal motility [6] 
supporting the idea that reduced fasting SBWC could be an indicator of excessive small bowel 
motility. We planned to exploit this new , non-invasive, highly patient acceptable technique to 
assess small and large bowel water in conditions known to be associated with SIBO such as 
scleroderma [7] and coeliac disease [8] and to compare this with our data in IBS-D, where there 
has been much interest in the possibility of SIBO as a cause of symptoms. 
We hypothesised that resting SBWC would be increased in coeliac and scleroderma patients. 
The logic being that increased SBWC in untreated CD patients would reflect both the net effect of 
impaired absorption associated with villous atrophy and increased secretion associated crypt 
hyperplasia and also the impaired motility reported in untreated coeliac disease [9, 10] while 
increased SBWC in SCD would reflect the associated impaired motility and reduced absorption. 
We planned to compare these with a group of previously studied IBS-D patients who acted as a 
control for the effect of diarrhoea. 
Materials and methods: 
Subjects: 
20 patients who were newly diagnosed with CD and on a gluten diet were recruited from 
gastroenterology clinics in secondary care (Nottingham University Hospital Trusts, Nottingham 
and Royal Hallamshire Hospital and University of Sheffield, Sheffield). Diagnosis of coeliac 
 disease was confirmed by duodenal (D2) biopsy. 15 patients with SCD who had gastrointestinal 
symptoms such as oesophageal reflux, abdominal pain, diarrhoea and constipation were 
recruited from a secondary care hospital (Nottingham Treatment Centre and Nottingham 
University Hospitals Trusts, Nottingham). The results from these 2 groups were compared with 
previous groups of 20 healthy volunteers (HV) and 26 untreated irritable bowel syndrome with 
diarrhoea (IBS-D) patients who underwent similar MRI fasting scans using the same criteria and 
restrictions as previously reported[11]. The IBS-D patients satisfied the Rome III criteria for IBS-D 
[12] and had been evaluated to exclude other causes of diarrhoeal disorders including coeliac 
disease, microscopic colitis and bile salt diarrhoea. 
This study was approved by the local ethics committees (06/Q2404/74, 10/H0906/50, L/07/2011).  
All subjects had given written consent and the study was carried out according to the Good 
Clinical Practice Principles and Declaration of Helsinki. All subjects were asked to abstain from 
alcohol, caffeine and strenuous exercise from the night before. If they were on any medication 
that might have affected gastrointestinal motility, this was stopped a week before the study day. 
Subjects were asked to fast overnight before the study day. All subjects had completed a MRI 
safety questionnaire to ensure safety and exclude any MRI incompatible metal implants. All 
subjects were asked to fill in a 7-day stool diary based on the Bristol Stool Form Scale, Hospital 
Anxiety and Depression Questionnaire and the Patient Health Questionnaire 15 (PHQ-15).  
MRI scanning protocol: 
All subjects were scanned in the 1.5 T Philips Achieva MRI scanner (Philips, Best, The 
Netherlands) in the morning.  Subjects were in a supine position with a SENSE-4 element body 
coil wrapped around the abdomen during the scanning phase. Subjects were in the scanner for 
approximately 15 minutes. 3 different imaging sequences were used for this study. Firstly, a 
coronal dual echo fast field echo (FFE) sequence was used to visualise the abdominal anatomy. 
This acquisition has 24 coronal planes and 45 continuous transverse images with a resolution of 
1.76 mm x 1.76 mm and a slice thickness of 7mm.  Secondly, small bowel water was assessed 
 using similar protocol to our previous studies [5, 6, 11]. This is a single breath-hold scan using a 
single shot, fast spin echo sequence which gives a high intensity signals from areas with free 
fluid and little signal from other body tissues. The third imaging sequence was to assess colonic 
volumes. This method was recently described and it involves a coronal dual echo FFE sequence 
with 24 continuous slices with an in-plane resolution of 1.76 x 1.76 mm and 7 mm slice thickness 
[13]. All these sequences were done in an expiration breath holds of between 15 to 24 s.  
Data analysis and statistics: 
Data was compared with a cohort of 20 HV who previously had a baseline fasting MRI scan as 
part of other research studies.  These subjects were age and sex matched to the cohort of CD 
patients. 
SBWC measurement was analysed with an in-house software which was previously described 
and validated [5] against naso-duodenal infusion of mannitol/ saline into the small bowel. The 
colonic volumes were manually segmented from the coronal images using Analyze9TM software 
(Mayo Foundation, Rochester, MN, USA). The total colonic volume is a total sum of the 
segmented colon measured from each image slices [13]. The volumes of small bowel water 
content and colonic volumes are expressed in millilitres (mL). 
Power and statistical analysis: 
Power calculation was not performed as these MRI assessments have never been performed 
before in such subjects.  
Statistical analysis was carried out using GraphPad Prism 6 for Windows (GraphPad Software, 
La Jolla California, USA). Normality of the data was tested by using the D’Agostino and Pearson 
omnibus normality test. Comparisons between 2 groups were performed using a 2-tailed 
unpaired t test for variables with a normal distribution or the Mann-Whitney’s test for those with a 
non-normal distribution. For multiple comparisons, 1-way ANOVA was used for normally 
distributed variables and Kruskal-Wallis test for non-normally distributed variables. The data are 
expressed as mean (±standard deviation; SD) when normally distributed and as median 
 (interquartile range; IQ) when non-normally distributed. Results of comparison test is significant if 
p ≤ 0.05. Post-hoc assessments were performed by using Bonferroni’s multiple comparison test 
for normally distributed variables and Dunn’s multiple comparison test for non-normally 
distributed variables. In the post-hoc assessments, result was considered significant if p≤0.03, 
thus accounting for the effect of multiple comparisons. 
 
Results: 
 
General demographics 
All subjects tolerated the MRI scanning protocol well. There were no adverse events during this 
study period. 20 CD patients (12 female and 8 male; age 45.614.1), 15 SCD (13 female and 2 
male; age 62.912.9), were recruited and compared with previously scanned 26 IBS-D patients 
(17 female and 9 male; 48.511.0) and 20 HV (12 female and 8 male; age 42.915.3). 5 of 20 
CD had iron deficiency anaemia, low folate and low B12 levels were each noted in 1 of 20 but 
none had hypocalcaemia or hypoalbuminaemia. This group was further subtyped according to 
the D2 biopsy results based on the modified Marsh-Oberhuber grading system for CD [14]. 8 CD 
had Marsh 3c, 8CD had Marsh 3b, 2 CD had Marsh 3a and 2 CD had Marsh 1. 
Bowel patterns 
As Figure 1 and Table 1 show there was a significantly increased daily stool frequency in all 3 
patient groups compared to HV. Average Bristol Stool Form score was also increased in all 3 
patient groups but only for IBS-D did this reach statistical significance.   
Psychological assessments  
Both CD and SCD showed similar PHQ-15 scores to IBS-D patients and significantly higher than 
the HV. Similarly, patients’ anxiety and depression scores were all increased compared with HV. 
(See Table 1). 
 Small bowel water content (SBWC) 
The MRI scans of the fasting small bowel showed significantly increased SBWC in the CD group 
compared with HV and IBS-D groups being 109 (53-224) versus 53 (31-98) mL and 42 (28-67) 
mL respectively; p<0.01(Kruskal-Wallis). There was no significant difference in fasting SBWC 
between the CD and SCD groups, 109 (53-224) and 77 (39-158) respectively; adjusted p >0.9. 
There was increased in fasting SBWC in SCD compared to the IBS-D (adjusted p=0.13) but not 
the HV group; adjusted p >0.9 (Figure 2). In the CD group, there was no difference in the fasting 
SBWC when comparing within the group who had anaemia (n=5) vs normal haemoglobin level 
(n=15). The values were 178 (63-870) and 107 (50-148) ml respectively, p=0.31. 
Figure 3 shows some examples of coronal image of the abdomen from a (A) HV, (B) patient with 
CD and (C) patient with SCD. The bright signal represents free water. Image B shows a CD 
patient with an extremely large volume of water in the small bowel compared to a HV. MRI 
analysis of the small bowel water content showed 1334 mL of free fluid in the small bowel.  
Image C shows dilated small bowel and free water in the small bowel of a SCD patient. Most of 
the water appears to be in the proximal small bowel. 
Total colonic volume 
Overall there were no significant difference between CD (547 [442-786]) versus HV (612 [445-
746]) mL; p=0.89, IBS-D (521 [428-757]) mL versus HV; p=0.67 and SCD (511 [453-789]) mL 
versus HV; p=0.65. (Figure 4). 
However, in the CD group, patients were further subtyped according to the severity of the D2 
biopsy based on the modified Marsh grading (Figure 5). There was a significant difference in the 
total colonic volumes as the severity of the Marsh 3 subtype grading increased. The total colonic 
volumes for the Marsh 3a, 3b and 3c subtypes were 395 (355-436), 519 (423-757) and 696 (528-
806) mL respectively; p=0.05. The stool frequency in Marsh 3c at 1.2 (1.0-1.3) was reduced 
compared to grade 3a and 3b which were 1.4 (1.0-3.0), 1.9 (1.6-2.1) and respectively; p= 0.02 
(Kruskal-Wallis). See figure 6. 
 Correlation between MR parameters and bowel symptoms 
There were no correlations between fasting SBWC and psychological distress symptoms such as 
anxiety or depression. There were no significant correlations between fasting SBWC and stool 
frequency and consistency (Table 2). 
Discussion   
This is the first attempt to relate fasting SBWC to clinical features and as such provides new 
insights into disease but also raises many new questions. We were not able to perform a power 
calculation prior to the start of the study as MRI has never been performed in these groups of 
patients. However with  our normal fasting small bowel water content of 53(33) ml from a recently 
performed study in normal volunteers[15]  we can calculate that using our technique in 25 healthy 
volunteers we would be able to detect a 27 ml difference with an 80% power. Whether such an 
increase would be clinically significant remains to be determined however the striking variability in 
fasting small bowel motor activity which occurs during the passage of the migrating motor 
complex suggests that any change would need to be substantial to be able to be detected by a 
single measurement which is not synchronized to the motor patterns. Plainly the effects we 
observed in our patients were substantial since the statistical test performed showed a p value of 
<0.01 is very robust and the difference seen would not be due to chance.  
The increase in SBWC in untreated coeliac disease that we observed may represent the 
imbalance between absorption and secretion created by loss of the absorptive function of villi 
leaving the crypts, whose main function is secretion [16]. It could also be secondary to the excess 
serotonin, characteristic of coeliacs [17-19] which has a stimulatory effect on submucosa enteric 
nerves which drive secretion [20-22]. Equally, given the documented disturbance in gastric 
emptying and postprandial motility in untreated coeliac disease [23] it may represent impairment 
of MMCs, something that could be easily tested.  This increased fasting secretion would 
predispose to SIBO which is detected in a proportion of untreated coeliacs, particularly those with 
more severe disease [8].   
 We found that overall the changes in small bowel water in coeliac disease were not accompanied 
by marked changes in colonic volumes. Our previous work has shown that colonic volumes are 
rather constant [13], possibly because subjects control this by timing defecation to avoid the 
unpleasant sensation caused by over distension. However, in our study, it is interesting to find 
that the more severely damaged small bowel mucosa as assessed by the modified Marsh grade 
was associated with larger colonic volumes. One possible explanation is that the elevated 
Peptide YY (PYY) [24, 25] and Glucagon-like peptide 1 (GLP2) [26], described in untreated 
coeliac disease may inhibit intestinal motility leading to an enlargement of both the small bowel 
and the colon. This was only observed in a small number of patients but it could be tested by 
repeating our study involving a larger cohort of CD patients before and after a gluten free diet 
along with measuring postprandial blood levels of these peptides. 
Scleroderma deranges small bowel function by the loss of smooth muscle and fibrosis [27] which  
results in impaired peristalsis in both oesophagus and small intestine. Delayed orocaecal transit 
is common and 2/3 of patients demonstrate SIBO [7]. The increased fasting contents we have 
demonstrated are likely due to a combination of reduce small bowel tone and impaired or 
reduced MMC activity which normally “sweeps” the intestine clear. The slowly moving intestinal 
contents in these patients would provide ideal conditions for bacteria to proliferate. These 
increases in SBWC contrast with the decrease seen in IBS-D, where motility is enhanced [28, 29] 
and as we showed SBWC reduced, possibly driven by anxiety or stress [11, 30, 31]. 
One limitation of our studies is that we did not prepare our subjects in any way nor attempt to 
synchronise our scan time to the periodicity of the MMC. We would expect the SBWC to vary in 
relation to the occurrence of the MMC, being much less just after an MMC had passed distally. 
This may account for the variability in fasting SBWC seen in all groups. Unfortunately recording 
small bowel motility to ensure scanning occurred at the same time in the fasting cycle would 
involve intubation, which we know reduces fasting SBWC [6], possibly because it stimulates 
 propulsive motility [32]. MRI assessment of motility is coming of age and it may be possible in the 
future to record both motility and SBWC.  
Our findings throw light on the possible causes of SIBO in coeliacs and scleroderma. These 
ideas should now be tested in a larger study in which the association of SBWC and SIBO is 
assessed in a group of untreated coeliacs before and after institution of a gluten-free diet. It may 
also be worthwhile looking at whether prokinetics can reduce fasting SBWC in scleroderma and 
whether this will reduce the incidence of SIBO in this patient group. 
Authorship Statement: 
Guarantor of the article: Professor Robin Spiller 
Specific author contributions: 
 
CL, KG and SF contributed to the design of the study, performed the research, collected and 
analysed the data and wrote the paper 
DSS and PL recruited participants and wrote the paper 
LM, SP, CLH and CC performed the research, collected and analysed data and wrote the paper 
RS and PG designed of the study, analysed data and wrote the paper. 
All authors approved the final version of the manuscript. 
 
Acknowledgements 
We are grateful for the support from the NIHR Nottingham Digestive Diseases Biomedical 
Research Centre. 
Funding 
None 
Disclosures 
The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or 
the Department of Health. The authors have no competing interests. 
 References: 
1. Deloose, E., et al., The migrating motor complex: control mechanisms and its role in health and disease. Nat 
Rev Gastroenterol Hepatol, 2012. 9(5): p. 271-85. 
2. Vantrappen, G., et al., The interdigestive motor complex of normal subjects and patients with bacterial 
overgrowth of the small intestine. J Clin Invest, 1977. 59(6): p. 1158-66. 
3. Soudah, H.C., W.L. Hasler, and C. Owyang, Effect of octreotide on intestinal motility and bacterial 
overgrowth in scleroderma. N Engl J Med, 1991. 325(21): p. 1461-7. 
4. Bjerkelund, C.J. and O.W. Husebye, The clinical and roentgenological findings in steatorrhea of varying 
etiology. Am J Dig Dis, 1950. 17(5): p. 139-49. 
5. Hoad, C.L., et al., Non-invasive quantification of small bowel water content by MRI: a validation study. Phys 
Med Biol, 2007. 52(23): p. 6909-22. 
6. Marciani, L., et al., Effects of a 5-HT(3) antagonist, ondansetron, on fasting and postprandial small bowel 
water content assessed by magnetic resonance imaging. Aliment Pharmacol Ther, 2010. 32(5): p. 655-63. 
7. Parodi, A., et al., Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical 
effectiveness of its eradication. Am J Gastroenterol, 2008. 103(5): p. 1257-62. 
8. Rubio-Tapia, A., et al., Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture 
of intestinal aspirate in celiac disease. J Clin Gastroenterol, 2009. 43(2): p. 157-61. 
9. Bai, J.C., et al., Abnormal colonic transit time in untreated celiac sprue. Acta Gastroenterol Latinoam, 1995. 
25(5): p. 277-84. 
10. Spiller, R.C., et al., Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with 
steatorrhoea caused by partially treated coeliac disease. Gut, 1987. 28(10): p. 1275-82. 
11. Marciani, L., et al., Postprandial changes in small bowel water content in healthy subjects and patients with 
irritable bowel syndrome. Gastroenterology, 2010. 138(2): p. 469-77, 477 e1. 
12. Longstreth, G.F., et al., Functional bowel disorders. Gastroenterology, 2006. 130(5): p. 1480-91. 
13. Pritchard, S.E., et al., Fasting and postprandial volumes of the undisturbed colon: normal values and 
changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI. Neurogastroenterol 
Motil, 2014. 26(1): p. 124-30. 
14. Dickson, B.C., C.J. Streutker, and R. Chetty, Coeliac disease: an update for pathologists. J Clin Pathol, 2006. 
59(10): p. 1008-16. 
15. Wilkinson-Smith, V.C., et al., Insights Into the Different Effects of Food on Intestinal Secretion Using 
Magnetic Resonance Imaging. JPEN J Parenter Enteral Nutr, 2018. 42(8): p. 1342-1348. 
16. Mellander, A., H. Abrahamsson, and H. Sjovall, Duodenal secretomotor function in untreated coeliac 
disease. Scand J Gastroenterol, 1995. 30(4): p. 337-43. 
17. Sjolund, K. and A. Nobin, Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease. 
Scand J Gastroenterol, 1985. 20(3): p. 304-8. 
18. Wheeler, E.E. and D.N. Challacombe, Quantification of enterochromaffin cells with serotonin 
immunoreactivity in the duodenal mucosa in coeliac disease. Arch Dis Child, 1984. 59(6): p. 523-7. 
19. Coleman, N.S., et al., Abnormalities of serotonin metabolism and their relation to symptoms in untreated 
celiac disease. Clin Gastroenterol Hepatol, 2006. 4(7): p. 874-81. 
20. Kellum, J.M., et al., Serotonin induces Cl- secretion in human jejunal mucosa in vitro via a nonneural 
pathway at a 5-HT4 receptor. Am J Physiol, 1994. 267(3 Pt 1): p. G357-63. 
21. Munck, L.K., et al., Failure of tropisetron to inhibit jejunal water and electrolyte secretion induced by 5-
hydroxytryptamine in healthy volunteers. Gut, 1994. 35(5): p. 637-40. 
22. Cooke, H.J., M. Sidhu, and Y.Z. Wang, 5-HT activates neural reflexes regulating secretion in the guinea-pig 
colon. Neurogastroenterol Motil, 1997. 9(3): p. 181-6. 
23. Usai, P., et al., Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac 
disease. Eur J Clin Invest, 1997. 27(12): p. 1009-15. 
24. Sjolund, K. and R. Ekman, Increased plasma levels of peptide YY in coeliac disease. Scand J Gastroenterol, 
1988. 23(3): p. 297-300. 
25. Wahab, P.J., W.P. Hopman, and J.B. Jansen, Basal and fat-stimulated plasma peptide YY levels in celiac 
disease. Dig Dis Sci, 2001. 46(11): p. 2504-9. 
26. Caddy, G.R., et al., Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and 
untreated coeliac disease. Eur J Gastroenterol Hepatol, 2006. 18(2): p. 195-202. 
 27. Young, M.A., S. Rose, and J.C. Reynolds, Gastrointestinal manifestations of scleroderma. Rheum Dis Clin 
North Am, 1996. 22(4): p. 797-823. 
28. Gorard, D.A., G.W. Libby, and M.J. Farthing, Ambulatory small intestinal motility in 'diarrhoea' predominant 
irritable bowel syndrome. Gut, 1994. 35(2): p. 203-10. 
29. Small, P.K., et al., Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome. 
Scand J Gastroenterol, 1997. 32(1): p. 39-47. 
30. Ditto, B., S.B. Miller, and R.G. Barr, A one-hour active coping stressor reduces small bowel transit time in 
healthy young adults. Psychosom Med, 1998. 60(1): p. 7-10. 
31. Cann, P.A., et al., Psychological stress and the passage of a standard meal through the stomach and small 
intestine in man. Gut, 1983. 24(3): p. 236-40. 
32. Read, N.W., et al., Effect of gastrointestinal intubation on the passage of a solid meal through the stomach 
and small intestine in humans. Gastroenterology, 1983. 84(6): p. 1568-72. 
 
 
Tables: 
Table 1: Baseline demographics and stool pattern 
Mean (SD) HV IBS-D Scleroderma Coeliac p (1-way 
Anova) 
  
N 20 26 15 20  
Female: 
male 
12:8 17:9 13:2 12:8  
Age (years) 42.915.3 48.5 11.0** 62.912.9*,*** 45.6 14.1 <0.01 
PHQ15 
(Median, 
IQR) 
1.0 (0-
3.0) 
11.0 (7.0-
13.5)* 
10.0 (8.0-
11.0)* 
10.0 (4.5-14.0) 
* 
<0.01 
Anxiety 4.52.7 7.74.1 6.53.7 8.33.7* 0.02 
Depression 1.41.2 4.83.3* 4.23.4* 4.852.9* <0.01 
Stools/ day 
(Median, 
IQR) 
1.1  
(1-1.6) 
2.4  
(1.8-3.7) *,*** 
2.1  
(1.9-3.7) * 
1.4  
(1.1-1.9)** 
<0.01 
(Kruskal-
wallis) 
Average 
stool 
consistency/ 
day 
3.330.7 4.51.4* 4.20.8 4.21.2 <0.01 
*adjusted p<0.03 versus HV following multiple comparison 
** adjusted p<0.03 versus SCD following multiple comparison 
*** adjusted p<0.03 versus CD following multiple comparison 
 
 
 
 
 
 
  
Table 2: Correlation between fasting SBWC with psychological distress, stool frequency 
and consistency 
Correlation between fasting 
SBWC 
Spearman, r P value 
Anxiety  0.20 0.10 
Depression 0.12 0.32 
Stool frequency -0.07 0.57 
Stool consistency -0.01 0.93 
 
 
 
  
 Figures and legends: 
 
Figure 1: Average stool frequency and consistency per day 
 
 
 
  
 Figure 2: Fasting small bowel water content between HV, IBS-D, SCD and CD 
 
 
  
 Figure 3: Coronal images of the abdomen showing bright signals which represent free water in 
the small bowel of a HV (image A), CD (image B) and SCD (image C) 
 
 
 
 
  
 Figure 4: Total colonic volume between each patient group versus HV 
 
 
 
  
 Figure 5: Total colonic volume versus severity of modified Marsh grading for D2 biopsy 
 
 
  
 Figure 6: Average stool frequency per day versus modified Marsh 3 subtypes in D2 histology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
